Search Results

Displaying Results 626-650 of 31989 "'SEE'"

Jun 01, 2026, 08:30 ET Cato Networks Sets New Benchmark, Cutting Time-to-Protect to 45 Minutes with Full Agentic CVE Mitigation

infrastructure. Cato is uniquely positioned because it brings together the three architectural requirements for agentic security operations: the network to see attacks, the platform to correlate context, and the cloud to enforce protection globally. This combination enables Cato to operationalize security at

More news about: Cato Networks


Jun 01, 2026, 08:30 ET Xtalks Announces its Life Science Webinar Calendar for June 2026

www.xtalks.com to see our upcoming webinars:CELL AND GENE THERAPYJun 10 - Overcoming Challenges in Viral Vector Manufacturing to Meet Commercial Demand

More news about: Xtalks


Jun 01, 2026, 08:30 ET Hyliion's KARNO™ Power Module Named 2026 Most Valuable Product by Consulting-Specifying Engineer

our KARNO business, and the other risks and uncertainties described under the heading "Risk Factors" in our SEC filings including in our Annual Report (See item 1A. Risk Factors) on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on February 25, 2026 for the year ended December 31,

More news about: Hyliion


Jun 01, 2026, 08:26 ET New Book Exposes Three-Barrier System Filtering Black Tech Professionals Out of the Job Market Before a Human Ever Reads Their Resume

professionals I work with are not failing because they lack qualifications or effort," says Veasey. "They are failing because the system was not designed to see them clearly. This book gives them the blueprint for navigating a process that was built around someone else."Research supports the claim. Audit

More news about: Byron Veasey Career Strategies


Jun 01, 2026, 08:15 ET A Texas Start-Up's Stubborn Bet That AI Can Solve Industrial Commerce

single largest available inventory of high quality, transactable industrial assets.They will not be the first to try, but we will be interested to see if they succeed.Resin8 operates primarily across Houston's Energy Corridor, Austin, and Calgary, with engineering based in Canada. The company

More news about: Resin8


Jun 01, 2026, 08:11 ET Cancer Vaccine Sustains 49 Percent Melanoma Reduction After 5 Years

underway to determine if intismeran helps as a firstline therapy in combination with pembrolizumab for melanoma. Already, the vaccine is being tested to see if it also works to prevent recurrence of lung and other cancers. For the KEYNOTE-942 trial, patients were enrolled at cancer centers in Australia

More news about: NYU Langone Health System


Jun 01, 2026, 08:03 ET Nearmap Expands Roof & Exterior Measurements as P&C Insurers Accelerate Claims Modernization

insights enable faster, more confident decisions across underwriting and claims, assessment and response, and planning and construction so teams can see truth, assess risk, and act with certainty. Founded in Australia in 2007, Nearmap stands as the definitive source of truth that shapes the livable world.For

More news about: Nearmap


Jun 01, 2026, 08:00 ET Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Cyclic IMS P20 Mass Spectrometer, a high-resolution structural and spatial omics platform designed to help scientists see biology more clearly, and act on it faster. Combining multipass Cyclic Ion Mobility Spectrometry with an enhanced suite of fragmentation, probing, and

More news about: Waters Corporation


Jun 01, 2026, 08:00 ET Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Cyclic IMS P20 Mass Spectrometer, a high-resolution structural and spatial omics platform designed to help scientists see biology more clearly, and act on it faster. Combining multipass Cyclic Ion Mobility Spectrometry with an enhanced suite of fragmentation, probing, and

More news about: Waters Corporation


Jun 01, 2026, 08:00 ET Peptide Tracker Sets the New Standard for Peptide Protocol Tracking on iOS

GHK-Cu.Injection Reminders: Notifications matched to the schedule you entered, including custom timing windows.Adherence Tracking: See logged versus scheduled doses on every protocol to catch drift early.The app also includes free reconstitution and half-life calculators,

More news about: Peptide Tracker


Jun 01, 2026, 08:00 ET Local Bounti Named as Exclusive CEA Honoree on the TIME World's Growth Leaders 2026 List

15% while improving its adjusted EBITDA loss1 by 35% year-over-year.1Adjusted EBITDA loss is a non-GAAP measure. See the reconciliation of this non-GAAP measure to the most directly comparable GAAP measure in our most recent earnings release at investors.localbounti.com.About

More news about: Local Bounti


Jun 01, 2026, 08:00 ET Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

acquisition modes in LC-MS/MS – and layering in a new benchmark for MS imaging speed and throughput with our DESI XS – this platform empowers researchers to see more biology, accelerate discovery, and make confident decisions. The Xevo MRT P10 MS represents a powerful step forward for our customers working to

More news about: Waters Corporation


Jun 01, 2026, 08:00 ET Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

acquisition modes in LC-MS/MS – and layering in a new benchmark for MS imaging speed and throughput with our DESI XS – this platform empowers researchers to see more biology, accelerate discovery, and make confident decisions. The Xevo MRT P10 MS represents a powerful step forward for our customers working to

More news about: Waters Corporation


Jun 01, 2026, 08:00 ET Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis

most common adverse reactions occurring in ≥2% of patients receiving ZAYNICH were diarrhea, hypertension, headache, and hypokalemia.Please see

More news about: Wockhardt


Jun 01, 2026, 07:30 ET Perpetua Resources Advances Construction of the Stibnite Gold Project

Forward-Looking Information. For further information on these and other risks and uncertainties that may affect the Company's business and liquidity, see the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's filings with

More news about: Perpetua Resources Corp.


Jun 01, 2026, 07:30 ET Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation

utilization and lactate production, direct readouts of enhanced glycolytic flux, confirming expected PKM2 activation in intact human brain tissue (see Figure 1).   Maintenance of the enhanced glycolytic flux well after removing drug in the blood supply suggests a durable PKM2 tetramer state, further

More news about: Biohaven Ltd.


Jun 01, 2026, 07:02 ET Sitemetric Launches the Most Advanced AI Camera for Construction -- Built to Know the Worksite

Generic security cameras see motion. The Sitemetric AI Camera understands construction. Its proprietary AI engine is trained to recognize the equipment, behaviors, and hazards found

More news about: SITEMETRIC


Jun 01, 2026, 07:00 ET Monster Energy's Luca Shaw Takes Victory at the UCI Downhill Mountain Bike World Cup in Loudenvielle

authenticity and the core of what its athletes and musicians represent. More than a drink, it's the way of life lived by athletes, bands, believers, and fans. See more about Monster Energy, including all of its drinks, at

More news about: Monster Energy


Jun 01, 2026, 07:00 ET Pathlock Reinforces Its Leadership in ERP Security and Controls for the AI Era

generation of ERP Security and Controls."— Damon Tompkins, CEO, Pathlock"Working with Fortune 500 companies every day, we see how dramatically the scale and complexity of enterprise activity has evolved. Control models built 10 years ago no longer meet the needs of today's AI-driven,

More news about: Pathlock


Jun 01, 2026, 07:00 ET Full Circle Lithium Announces First Canadian Sales to Ottawa Fire Services

and fire-fighting related government regulations and potential client product specifications, and applicable environmental requirements and issues – see additional risks described in FCL's public filings. Actual results, developments and timetables could vary significantly from the estimates presented.

More news about: Full Circle Lithium Inc


Jun 01, 2026, 06:45 ET LACTAID® Invites Ice Cream Lovers to Ditch the Sunday Scaries with LACTAID® Sunday Dairies

PURCHASE NECESSARY. U.S./D.C. residents 18+, except those in voided states. Ends 8/30/2026. Void in CO, LA, MN, NJ, NV, RI, TN and where prohibited. See

More news about: Kenvue Inc.


Jun 01, 2026, 06:30 ET ArmorSource Wins $17.6M U.S. Army Contract for 25,000 ACH Gen II Helmet Systems

Contract number SPE1C1-26-C-0016, following a comprehensive procurement process. Deliveries under the new order are scheduled to begin in 2027."We see this award as a sign of trust from the U.S. government, the U.S. Army, PEO Soldier, and the Defense Logistics Agency," said Todd Barnes, Government Programs

More news about: ArmorSource LLC


Jun 01, 2026, 06:30 ET ArmorSource Wins $17.6M U.S. Army Contract for 25,000 ACH Gen II Helmet Systems

Contract number SPE1C1-26-C-0016, following a comprehensive procurement process. Deliveries under the new order are scheduled to begin in 2027."We see this award as a sign of trust from the U.S. government, the U.S. Army, PEO Soldier, and the Defense Logistics Agency," said Todd Barnes, Government Programs

More news about: ArmorSource LLC


Jun 01, 2026, 06:30 ET Schneider Electric Selects Weidmüller SNAP IN Technology for New TeSys Series, Cutting Wiring Time by Up to 75%

-- See SNAP IN technology in Schneider's TeSys Series at Automate 2026,June 22-25 in Chicago in both Weidmuller USA and Schneider Booths --RICHMOND, Va., June 1, 2026 /PRNewswire/

More news about: Weidmuller


Jun 01, 2026, 06:30 ET Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

Advisory Board and Nobel Prize Laureate for his groundbreaking work on RNA splicing. "The RNA revolution continues and I couldn't be more delighted to see what Skyhawk is doing to advance it.""The increasing separation of the clinical trajectories of treated participants from natural history expectations

More news about: Skyhawk Therapeutics


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.